Profile change history

What changed for FOXO4-DRI?

A deterministic history of records added to PeptideScanner and preserved profile or record revisions connected through the reviewed FOXO4-DRI identity.

2Total events
2Record additions
0Version changes
2Cited source years

Collection chronology

Evidence added to PeptideScanner

Browse all 2 connected records →

Showing the latest 2 additions by PeptideScanner publication date; the complete connected record set remains available on the cross-source timeline. Most recent addition: November 16, 2026.

Record added

Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes.

PubMed lists PMID 33996787 in Frontiers in bioengineering and biotechnology as Journal Article, with publication-date metadata of 2021-04-29 (day precision). PeptideScanner associated the retained record with the identity slug foxo4-dri. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
February 1, 2022
Evidence lane
Literature metadata
Record added

The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4-DRI.

PubMed lists PMID 40593617 in Nature communications as Journal Article, with publication-date metadata of 2025-07-01 (day precision). PeptideScanner associated the retained record with the identity slug foxo4-dri. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

PeptideScanner change date
November 16, 2026
Cited source date
July 4, 2025
Evidence lane
Literature metadata